Make a Donation
Donate to Accelerate a Cure for Creatine Deficiencies
Support life-changing research, earlier diagnosis, and new therapies by donating to the Association for Creatine Deficiencies. Your gift helps children and adults affected by Cerebral Creatine Deficiency Syndromes (CCDS) access hope, treatment progress, and a faster path to clinical trials.
The Association for Creatine Deficiencies is a charitable 501c3 organization and contributions may be tax-deductible. Our tax EIN# is: 46-2133007 Learn more about our initiatives here.
How Your Donation Advances Creatine Deficiency Research
Speed Proven Research
With more than $1.5 million already invested in CCDS research, we are expanding promising work in:
Gene therapy for creatine transporter deficiency
Drug development and treatment discovery
Translational research that moves therapies toward patient access
Your support helps transform promising science into viable treatment options.
Award Research Acceleration Grants
Donations help fund Research Acceleration Grants that:
Move therapies toward IND submission readiness
Support preclinical validation and regulatory preparation
Shorten the timeline to human clinical trials
Our goal: trial-ready therapies by 2028.
Expand Newborn Screening & Early Diagnosis
Funding also supports critical work to:
Advance CTD newborn screening research
Continue GAMT screening advocacy
Improve early diagnosis for all three CCDS disorders
Earlier diagnosis means earlier treatment, better outcomes, and a dramatically shorter diagnostic journey for families.
Donate with credit card or bank transfer
Mail a Check to:
ACD
6965 El Camino Real, Suite 105-598
Carlsbad, CA 92009
Donate Stock
Securities can be gifted to ACD via electronic transfer (in which your broker transfers shares using the ACD DTC number) or by physically mailing the paper certificates to ACD. Electronic transfer is preferred if possible. Please contact your broker to initiate the transfer. Your broker can contact heidi@creatineinfo.org to obtain the DTC number and further details.
Race for a Cure: Funding the Next Breakthroughs
The Race for a Cure campaign, launched in 2025, aims to raise $8 million in 2026 to accelerate research, expand newborn screening, and move promising therapies toward clinical trials by 2028.
This campaign is designed to move creatine deficiency research out of the laboratory and into real-world treatment pathways — faster than ever before.
When you donate today, you help drive measurable progress toward treatments and a cure.